Chronic graft-versus-host disease in the era of reduced-intensity conditioning

被引:15
作者
Subramaniam, D. S.
Fowler, D. H.
Pavletic, S. Z.
机构
[1] NCI, Graft Versus Host & Autoimmun Unit, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA
[2] Georgetown Univ Hosp, Lombardi Canc Ctr, Div Hematol Oncol, Washington, DC 20007 USA
关键词
chronic graft-versus-host disease; reduced-intensity conditioning; hematopoietic stem cell transplantation;
D O I
10.1038/sj.leu.2404642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the past decade the field of hematopoietic stem cell transplantation has entered a new era with the introduction of reduced intensity conditioning (RIC) regimens. The impact of RIC on the incidence of chronic graft-versus-host disease (GVHD) has not been evaluated systematically. Factors confounding such analyses include short follow-up in studies, absence of prospective comparison trials, use of a variety of RIC regimens, lack of uniform GVHD prophylaxis and lack of rigorous criteria for the diagnosis and staging of chronic GVHD. This review discusses factors that appear to influence the incidence and clinical presentation of chronic GVHD in the RIC transplantation era. Overall, RIC seems to decrease the incidence and severity of acute GVHD through day 100 posttransplant when compared to conventional conditioning; however, there is little evidence to suggest that chronic GVHD is reduced after RIC. For the more definitive assessments of chronic GVHD after RIC it will be important to study this question in prospective comparison trials with long duration of follow-up. The recent National Institutes of Health chronic GVHD consensus project recommendations provide now the critically needed standardized guidelines for the diagnosis, classification and staging of chronic GVHD.
引用
收藏
页码:853 / 859
页数:7
相关论文
共 55 条
  • [1] Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials
    al-Jurf, M
    Aranha, F
    Annassetti, C
    Apperley, JF
    Baynes, R
    Bensinger, WI
    Blaise, D
    Chaudhary, MA
    Clarke, M
    Cornelissen, JJ
    Couban, S
    Cutler, C
    Djulbegovic, B
    Gyger, M
    Gratwohl, A
    Heldal, D
    Van der Holt, B
    Hozo, I
    Kuentz, M
    Kumar, A
    Lipton, J
    Matchamm, J
    Mohty, M
    Morton, J
    Panzarella, T
    Powles, R
    Richards, SM
    Sahovic, E
    Schmitz, N
    Simpson, DR
    Sirohi, B
    Soares, HP
    de Souza, CA
    Vigorito, AC
    Wheatley, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5074 - 5087
  • [2] Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
    Anderson, BE
    McNiff, JM
    Matte, C
    Athanasiadis, I
    Shlomchik, WD
    Shlomchik, MJ
    [J]. BLOOD, 2004, 104 (05) : 1565 - 1573
  • [3] Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
    Antin, JH
    Weisdorf, D
    Neuberg, D
    Nicklow, R
    Clouthier, S
    Lee, SJ
    Alyea, E
    McGarigle, C
    Blazar, BR
    Sonis, S
    Soiffer, RJ
    Ferrara, JLM
    [J]. BLOOD, 2002, 100 (10) : 3479 - 3483
  • [4] Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
    Aoudjhane, M
    Labopin, M
    Gorin, NC
    Shimoni, A
    Ruutu, T
    Kolb, HJ
    Frassoni, F
    Boiron, JM
    Yin, JL
    Finke, J
    Shouten, H
    Blaise, D
    Falda, M
    Fauser, AA
    Esteve, J
    Polge, E
    Slavin, S
    Niederwieser, D
    Nagler, A
    Rocha, V
    [J]. LEUKEMIA, 2005, 19 (12) : 2304 - 2312
  • [5] Antithymocyte globulin for prevention of graft-versus-host disease
    Bacigalupo, A
    [J]. CURRENT OPINION IN HEMATOLOGY, 2005, 12 (06) : 457 - 462
  • [6] Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning
    Barker, JN
    Weisdorf, DJ
    DeFor, TE
    Blazar, BR
    Miller, JS
    Wagner, JE
    [J]. BLOOD, 2003, 102 (05) : 1915 - 1919
  • [7] High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation
    Baron, F
    Maris, MB
    Storer, BE
    Sandmaier, BM
    Panse, JP
    Chauncey, TR
    Sorror, M
    Little, MT
    Maloney, DG
    Storb, R
    Heimfeld, S
    [J]. LEUKEMIA, 2005, 19 (05) : 822 - 828
  • [8] Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning
    Baron, F
    Maris, MB
    Sandmaier, BM
    Storer, BE
    Sorror, M
    Diaconescu, R
    Woolfrey, AE
    Chauncey, TR
    Flowers, MED
    Mielcarck, M
    Maloney, DG
    Storb, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) : 1993 - 2003
  • [9] Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
    Baron, F
    Baker, JE
    Storb, R
    Gooley, TA
    Sandmaier, BM
    Maris, MB
    Maloney, DG
    Heimfeld, S
    Oparin, D
    Zellmer, E
    Radich, JP
    Grumet, FC
    Blume, KG
    Chauncey, TR
    Little, MT
    [J]. BLOOD, 2004, 104 (08) : 2254 - 2262
  • [10] BARON F, 2005, CLIN ADV HEMATOL ONC, V10, P799